Original Research

Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

Lai XX, Xu RA, Li YP, Yang H

OncoTargets and Therapy 2016, 9:2421-2428

Published Date: 21 April 2016